Daraprim (pyrimethamine) is a small molecule pharmaceutical. Pyrimethamine was first approved as Daraprim on 1982-01-01. It is used to treat aids-related opportunistic infections, falciparum malaria, malaria, and toxoplasmosis in the USA. It is known to target multidrug and toxin extrusion protein 2, multidrug and toxin extrusion protein 1, Pteridine reductase, and beta-hexosaminidase subunit beta.
|Indication||aids-related opportunistic infections, falciparum malaria, malaria, toxoplasmosis|